In vitro studies of cultured salivary gland cells and gland slices have indicated that there may be regulated translocation of AQP5 between the apical plasma membrane and intracellular compartments of the secretory cells. However it remains unknown whether AQP5 in salivary glands is subject to regulated trafficking in vivo. In order to examine this possibility, we have investigated the subcellular localization of AQP5 in rat parotid and submandibular glands fixed in vivo under conditions of stimulated or inhibited salivary secretion.
Introduction
Fluid transport in salivary glands is thought to be driven osmotically in response to transepithelial salt gradients that are generated by ion transport systems localized to the apical and basolateral membranes of the secretory cells. According to the classical two-stage hypothesis (5, 32) , a primary fluid containing plasma-like electrolyte concentrations is generated by the acinar cells, and the fluid is subsequently modified by solute reabsorption and secretion as it passes along the ductal system resulting in the final, hypotonic solution that enters the mouth. Therefore the principal site of water transport is likely to be the acini with relatively little transepithelial water movement occurring in the ducts.
Aquaporin (AQP) water channels are expressed in a variety of fluidtransporting epithelia, and it is increasingly clear that they are likely to play a significant role in salivary secretion. Several rat exocrine glands have been shown to express AQP5 at the luminal surface of the acinar cells. These include the lacrimal glands (11, 24) , the subepithelial glands of the upper airways (25) and the submandibular and parotid salivary glands (10, 25) .
AQP5 is highly expressed in the apical plasma membrane (29) , and based on the abundance of the channel it is predicted to play a significant role in saliva production. In support of this, knockout mice lacking AQP5 show markedly depressed rates of salivary secretion (19, 21) .
Rat salivary glands are innervated by both the sympathetic and parasympathetic branches of the autonomic nervous system. Stimulation of muscarinic receptors, -and -adrenoceptors and histamine receptors with their respective agonists all induce some secretion of saliva (5) . In general, parasympathetic stimulation produces the largest increase in salivary flow rate as a result of the activation of M3 muscarinic receptors on the acinar cells.
Noradrenaline released from sympathetic nerve endings acts at both -and -adrenergic receptors. Activation of -adrenoceptors induces secretion of the salivary proteins contained in zymogen granules by exocytosis, whereas activation of -adrenoceptors induces modest fluid secretion (3) . G-00480-2003 . R1 4 AQP5 is abundant in the apical domains of the serous acinar cells, secretory canaliculi and intercalated duct cells, and absent from the mucous acinar cells and striated duct cells in the rat (6, 25) . Within the serous acini, AQP5 is present in the microvilli protruding into intercellular secretory canaliculi, as determined by immunoelectron microscopy (6) . The issue of whether AQP5 may be subject to regulated intracellular trafficking was raised by work on cultured cells and in vitro experiments using gland slices (13, 14, 15, 31) .
However, this hypothesis has not been formally tested in vivo and no direct visualization of AQP5 redistribution has been reported.
In order to evaluate whether AQP5 is subject to intracellular translocation following stimulation or inhibition of salivation, we have undertaken a systematic investigation of the subcellular distribution of AQP5 in rat parotid and submandibular glands after treatment with pilocarpine (a muscarinic agonist), atropine (a muscarinic antagonist), epinephrine (an -adrenergic agonist), and phentolamine (an -adrenergic antagonist). The effect of these agents on AQP5 distribution was determined using laser confocal light microscopy and immunogold electron microscopy.
Methods

Preparation of experimental animals
Seven groups of normal male Munich-Wistar rats (250-300g bw; n=3 per group) were maintained on a standard diet, then fasted overnight prior to the experiment. Animals were anesthetized with Mebumal (0.75g/kg bw) prior to all studies. Each animal was treated as described, and at the designated times submandibular and parotid glands were perfusion fixed as described below. The drug dosages and exposure time were chosen according to comparable previous studies (2, 21, 22, 23) .
Group 1 (the control group) was injected intraperitoneally with 0.2 ml physiological saline alone and fixed after 10 min.
In groups 2 and 3, animals received a subcutaneous injection of pilocarpine hydrochloride (Sigma) in their neck at 10mg/kg bw. Animals were perfusion fixed 3 min after injection (group 2) or after 10 min (group 3). It should be noted that in intact animals, significant salivation only begins 2-3 min after subcutaneous injection of submaximal doses of pilocarpine and is reaching a maximum after 10 min (23).
In group 4, intraperitoneal atropine was administered at 1 mg/kg bw in physiological saline, and animals were fixed at 10 min.
In groups 5 and 6, epinephrine hydrochloride (Sigma) was injected via the left femoral vein at 0,1 mg/kg bw. Animals were fixed after 3 min (group 5) or 10 min (group 6).
In group 7 phentolamine (Regitine, 10 mg/ml) at 10 mg/kg bw was injected via the left femoral vein, and animals were fixed after 10 min of treatment.
At the designated times, the submandibular and parotid glands of the experimental animals were fixed by transcardiac perfusion with 4% paraformaldehyde in 0.1M cacodylate buffer, pH 7.4. In animals receiving G-00480-2003.R1 6 phentolamine, the blood pressure was monitored via a PE-50 catheter inserted into the left femoral artery (Sirecust 961 and Siredoc 220, Siemens, Munich, Germany). In animals with ten minute exposures to pilocarpine (group 3) and epinephrine (group 6), during stimulation saliva was aspirated from the mouth with a micropipette and collected in Eppendorf tubes. The volume of saliva was estimated gravimetrically. There was no measurable secretion of saliva in the control, atropine, or phentolamine groups, or in the pilocarpine or epinephrine groups after 3 min of treatment.
Antibodies
For immunohistochemistry, immunofluorescence and immunoelectron microscopy, previously characterized, affinity purified polyclonal antibodies to rat AQP5 (18, 25) were used. A previously characterized monoclonal Na + /K + -ATPase antibody (16) was used as a basolateral marker for double-label immunofluorescence experiments.
Immunohistochemistry for light microscopical examination
The rat parotid and submandibular glands were removed and post-fixed for 1 hour in the same fixative solution used for perfusion, then dehydrated in ethanol followed by xylene, and finally embedded in paraffin. Sections were cut at 2 µm thickness on a rotary microtome (Leica, Germany) then dewaxed and rehydrated.
For immunoperoxidase labeling (7), endogenous peroxidase was blocked by 0.5% H 2 O 2 in absolute methanol for 30 min at room temperature. For antigen retrieval, sections were placed in 1 mmol/l TRIS solution (pH 9.0) supplemented with 0.5 mM EGTA (3.6-di-oxa-octa-methylen-di-nitrilo-tetraacetic-acid) and heated in a microwave oven for 10 min. Nonspecific binding Immunolabeling controls were performed using antibodies preadsorbed with the immunizing peptide (data not shown).
Immunoelectron microscopy of rat salivary glands
For immunoelectron microscopy, the frozen samples were freeze-substituted in a Reichert AFS freeze substitution unit (20, 26, 27, 33) . In brief, the samples were sequentially equilibrated over three days in methanol containing 0.5% uranyl acetate at temperatures gradually raised from -80 o C to 
Results
Subcellular localization of AQP5 in salivary glands by light microscopy and by immunogold electron microscopy
Immunoperoxidase labeling with a rat AQP5 antibody and immunofluorescence double labeling for AQP5 and Na + /K + ATPase were performed on paraffin sections of rat parotid and submandibular glands. In the submandibular glands of untreated control animals ( Fig 1A,B) , AQP5 labeling was present abundantly in the apical domains of both acinar cells (arrows)
and intercalated duct cells (arrowheads). The staining appeared to be stronger in the intercalated ducts (inset in Fig. 1B) , consistent with previous studies (24) . In the rat parotid glands (Fig 1C,D) AQP5 labeling was associated exclusively with the apical membrane of the acinar cells and exhibited a punctate appearance. In contrast to the labeling pattern observed in the submandibular gland, no labeling was seen in the intercalated duct cells (ID, arrowheads in Fig 1D) of the parotid. No AQP5 labeling was observed in the striated ducts of either gland (e.g. SD in Fig 1D) . The double-labeling images also showed that there was no overlap in the distribution of AQP5 and the basolaterally located Na + /K + -ATPase (34).
Immunoelectron microscopy was performed to determine the subcellular distribution of AQP5. In the submandibular glands of control animals, extensive immunogold labeling was clearly associated with the apical plasma membranes of both intercalated duct cells ( Fig. 2A, C ) and acinar cells (not shown). In rat parotid acinar cells (Fig 2B) , the labeling was especially associated with the apical microvilli including those situated in the intercellular secretory canaliculi, consistent with previous observations (9) .
Immunoelectron microscopy also demonstrated that the punctate appearance of the AQP5 distribution in both glands was due to the clustering of labeling Stimulation with the muscarinic agonist pilocarpine dramatically increased saliva production, from being undetectable in the control animals to 1.2 ± 0.09 g/10 min (n=3; mean SD).
Light microscope immunohistochemistry after 3 min of pilocarpine exposure revealed that the AQP5 labeling was confined to the apical plasma membrane domains with little or no labeling of intracellular domains (Fig 3) . Compared to the controls, the apical labeling following pilocarpine administration became markedly more punctate in appearance after 10 min of drug exposure (Fig 4) in both the submandibular and parotid glands. This seemed to be due to the combination of clustering of AQP5 and dilatation of the lumen. Notably, both the punctate appearance (Fig 4C) and the dilatation of the lumen (Fig 4D) were more pronounced in the parotid gland than in the submandibular gland (Fig 4A,B) . Moreover, immunoelectron microscopy revealed that, as in the control animals, AQP5 was almost exclusively associated with the apical plasma membrane domains, particulary the microvilli. This was seen both Fig 6) . There was little evidence of any change in intracellular labeling in response to atropine treatment. Immunoelectron microscopy confirmed this and revealed almost exclusive labeling of the apical plasma membrane domains, including the microvilli of both acinar and intercalated duct cells (Fig 7) . On average, 4 0.9 % (mean SEM) of the gold particles were intracellular and 96 0.9% (mean SEM) were localized to the apical plasma membrane domains. Thus, no major changes in the subcellular localization of AQP5 were observed in response to atropine treatment.
Effects of epinephrine on the subcellular localization of AQP5
Stimulation with the -adrenoceptor agonist epinephrine also increased saliva production, although to a much smaller extent than pilocarpine. Laser scanning confocal microscopy revealed that the AQP5 labeling was confined to the apical plasma membrane domains regardless of the drug exposure time (3 or 10 min; Fig 8) . Immunoelecton microscopy confirmed these findings (data not shown). Thus there were no changes in the subcellular localization of AQP5 as compared to the control tissues.
Effects of phentolamine on the subcellular localization of AQP5
Treatment with the -adrenoceptor antagonist phentolamine was carried out with monitoring of blood pressure. After 1 min of drug administration the initial blood pressure of 90 mmHg had dropped as expected to 70-75 mmHg. It then remained at that level during the 10 minutes of treatment.
Immunoperoxidase and laser scanning confocal microscopy showed that the AQP5 labeling remained confined to the apical plasma membrane domains of acinar cells in the submandibular and parotid glands and the intercalated duct
12 cells in the submandibular gland. The distribution was again punctate in appearance, with little evidence of intracellular labeling (Fig 9) . Thus there were no changes in the subcellular localization of AQP5 as compared to the control tissues. This was confirmed by immunoelectron microscopy (data not shown).
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Discussion
Both the onset and cessation of salivary secretion can occur very rapidly. This is normally attributed to the rapid kinetics of intracellular Ca 2+ signalling and the virtually immediate response of Ca 2+ -activated ion channels at the apical and basolateral membranes. However, the water channel AQP5 also plays an important role in the generation of saliva, as evidenced by the reduction in volume and increase in osmolality of saliva in AQP5 null mice (19, 21) .
Several in vitro studies using membrane fractionation have shown evidence of the regulated trafficking of AQP5 in cultured salivary gland cells and gland slices (13, 14, 15, 31) . This, therefore, has raised the possibility that AQP5
translocation from intracellular vesicles to the apical plasma membrane may lead to an increase in water permeability following neuronal and hormonal stimulation. While this is unlikely to occur rapidly enough to be the rate- Light microscopy also showed that the immunolocalization of AQP5 at the apical membrane domains of the acinar cells became markedly more punctate 10 min after pilocarpine stimulation. This appeared to be due to clustering of AQP5 at the microvilli combined with a concurrent dilatation of the lumen, most conspicuously in the parotid gland (Fig. 4C) . Our immunoelectron microscopic findings confirmed that AQP5 labeling is indeed mainly associated with the microvilli. These protrude into the acinar lumen and intercellular secretory canaliculi in both the parotid and submandibular glands. They are also present in the intercalated ducts of the submandibular gland although there are also long stretches of apical membrane without AQP5 labeling ( Fig. 2A, 5C , 6B, 7B).
Salivary secretion is associated with a massive exocytosis, in part a reflection of increased numbers of granule fusion sites in the cell surface (4). Since the luminal and canalicular area of the gland acinus is small, the high rate of secretory granule fusion must be matched by rapid retrieval of membrane.
Although there is some dilatation of the acinar lumen, the increase in the apical membrane surface area during periods of enhanced secretion is clearly limited. The clustering of AQP5 at the microvilli may therefore be related to the high incidence of exocytosis in the intervening regions of the apical membrane. Consistent with this explanation, Matsuzaki and colleagues (24) reported that treatment with the -adrenergic agonist isoproterenol, which predominantly stimulates protein secretion, leads to a similar clustering of AQP5 labeling in rat parotid acinar cells together with a marked dilatation of the lumen and secretory canaliculi. 
